Schwarcz, S.; Nyerges, P.; BÃró, T.I.; Janka, E.; Bai, P.; Mikó, E.
Cytostatic Bacterial Metabolites Interfere with 5-Fluorouracil, Doxorubicin and Paclitaxel Efficiency in 4T1 Breast Cancer Cells. Molecules 2024, 29, 3073.
https://doi.org/10.3390/molecules29133073
AMA Style
Schwarcz S, Nyerges P, BÃró TI, Janka E, Bai P, Mikó E.
Cytostatic Bacterial Metabolites Interfere with 5-Fluorouracil, Doxorubicin and Paclitaxel Efficiency in 4T1 Breast Cancer Cells. Molecules. 2024; 29(13):3073.
https://doi.org/10.3390/molecules29133073
Chicago/Turabian Style
Schwarcz, Szandra, Petra Nyerges, TÃmea Ingrid BÃró, Eszter Janka, Péter Bai, and Edit Mikó.
2024. "Cytostatic Bacterial Metabolites Interfere with 5-Fluorouracil, Doxorubicin and Paclitaxel Efficiency in 4T1 Breast Cancer Cells" Molecules 29, no. 13: 3073.
https://doi.org/10.3390/molecules29133073
APA Style
Schwarcz, S., Nyerges, P., BÃró, T. I., Janka, E., Bai, P., & Mikó, E.
(2024). Cytostatic Bacterial Metabolites Interfere with 5-Fluorouracil, Doxorubicin and Paclitaxel Efficiency in 4T1 Breast Cancer Cells. Molecules, 29(13), 3073.
https://doi.org/10.3390/molecules29133073